Delivery Order SPE2DB20D3303-SPE2DB26FY2H7
- Not listed
- The Defense Logistics Agency awarded a $1,842.17 delivery order to AmerisourceBergen Drug Corp for Abilify Maintena ER 400 mg syringes, with performance at the contractor's Conshohocken, Pennsylvania headquarters and completion scheduled for September 16, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with the DLA. The award reflects the contractor's role as a critical...
- The Defense Logistics Agency awarded a $4,531.06 delivery order to AmerisourceBergen Drug Corp for Abilify Maintena ER 400 mg syringes, with an ultimate completion date of September 12, 2025. This is a firm fixed price contract with no set-aside designation, awarded on a competitive basis. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on May 20, 2025, for the supply of Abilify Maintena ER 400 mg syringes. The contract is a firm fixed-price delivery order with a ceiling value of $3,684.34 and an ultimate completion date of May 21, 2025. This award was not set-aside and was competitively awarded, reflecting the vendor's capability to meet federal procurement requirements. The delivery is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $24,305.05 by the Defense Logistics Agency on August 28, 2025, for the supply of Abilify Maintena ER 400 mg syringes. The contract is firm fixed price with an ultimate completion date of August 29, 2025, and represents a competitive award with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,684.34 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. This firm fixed-price contract, awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a non-set-aside competitive procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5,533.12 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 300 mg syringes, with an ultimate completion date of November 6, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The contract was executed on November 5, 2025, with performance to be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,764.94 on July 23, 2025, for the supply of Abilify Maintena ER 300 mg vials/syringes/cartridges. This firm fixed price delivery order, with an ultimate completion date of July 24, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply framework with the federal government. The award was not designated as a set-aside contract and was competitively awarded. Performance...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,842.17 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. This competitively awarded, firm fixed-price delivery order is set to be completed by June 30, 2025, and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The contract is classified as a non-set-aside procurement, indicating it was awarded through open...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $2,714.54 for the supply of Abilify Maintena Extended-Release (ER) 400 mg syringes. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 24, 2024. The contract is a firm-fixed-price delivery order, which is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The award, valued at $3,346.48, is for the supply of Abilify Maintena ER 400 mg syringes, a specialty pharmaceutical product. The order is placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and is valid through December 2025. This IDC serves as a primary vehicle for Amerisourcebergen to...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB26FY2H7Delivery Order
The Defense Logistics Agency awarded a $3,834.84 delivery order to AmerisourceBergen Drug Corp for Abilify Maintena ER 400 mg syringes under a firm fixed-price contract type. The order was competitively awarded with no set-aside designation and carries an ultimate completion date of November 7, 2025. AmerisourceBergen's Corporate Office, located in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical delivery. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive pharmaceutical support globally, enabling the company to supply a broad range of medications, vaccines, and medical supplies to military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare organizations. AmerisourceBergen's consistent performance as a major pharmaceutical distributor across multiple therapeutic domains demonstrates its capability to meet federal medical procurement requirements in support of military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 11/6/25 |